Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma

doi:10.3748/wjg.v11.i39.6104

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 39

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3374)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

372

HTML

2712

Figures (1-2)

156

Tables (1-4)

134

Sum=3374

Oct 21, 2005 (publication date) through Jul 28, 2024

Times Cited of This Article

Times Cited (60)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Oct 21, 2005; 11(39): 6104-6109
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6104

Table 3 Hospitalization or out-patient visits according to treatment

	TACE	TACE-PEI	P (Wilcoxon rank test)
IST (d)	33	44.67	0.46
OST (d)	2.72	3.07	0.75
ISO (d)	9.16	5.74	0.91

IST = average inpatient hospitalization because of treatment or complications; OST = average outpatient visits because of treatment or complications; ISO = average inpatient hospitalization for other reasons.

Citation: Becker G, Soezgen T, Olschewski M, Laubenberger J, Blum HE, Allgaier HP. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005; 11(39): 6104-6109
URL: https://www.wjgnet.com/1007-9327/full/v11/i39/6104.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i39.6104